Papers
1
Total Citations
11
H-Index
1
About
Max Jacobsen is a pioneering urologic surgeon whose research centers on advancing precision oncology through intraoperative imaging and targeted fluorescence-guided surgery. His most impactful work investigates OTL38, a folate-receptor-targeted fluorescent agent, in robotic-assisted laparoscopic partial nephrectomy. In a landmark 2021 study, Jacobsen demonstrated the safety and efficacy of this novel approach, enabling real-time visualization of renal cell carcinoma margins during minimally invasive procedures. This contribution has garnered 11 citations and represents a significant step toward reducing positive surgical margins and preserving healthy renal tissue. Jacobsen’s research bridges the gap between molecular targeting and surgical innovation, offering patients more precise cancer resection with fewer complications. His work has been recognized for its translational potential, positioning him as a leader in the emerging field of image-guided urologic surgery. By integrating fluorescence agents like OTL38 into robotic platforms, Jacobsen is reshaping the standard of care for kidney cancer, providing surgeons with a powerful tool to visualize tumors that might otherwise be missed. His ongoing efforts continue to push the boundaries of precision medicine in urology.
Research Focus
Key Achievements
Top Papers
- 1